Brighton Jones LLC’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.4M | Buy |
+15,617
| New | +$15.8M | 0.32% | 44 |
|
|
2025
Q4 | – | Sell |
-11,909
| Closed | -$9.09M | – | 557 |
|
|
2025
Q3 | $9.09M | Buy |
11,909
+1,021
| +9% | +$760K | 0.22% | 56 |
|
|
2025
Q2 | $8.49M | Buy |
10,888
+467
| +4% | +$363K | 0.23% | 58 |
|
|
2025
Q1 | $8.61M | Buy |
10,421
+824
| +9% | +$686K | 0.28% | 52 |
|
|
2024
Q4 | $7.41M | Buy |
9,597
+1,730
| +22% | +$1.43M | 0.21% | 60 |
|
|
2024
Q3 | $6.97M | Sell |
7,867
-3,630
| -32% | -$3.26M | 0.26% | 53 |
|
|
2024
Q2 | $10.4M | Buy |
11,497
+49
| +0.4% | +$39.2K | 0.34% | 45 |
|
|
2024
Q1 | $8.91M | Buy |
11,448
+1,774
| +18% | +$1.26M | 0.32% | 44 |
|
|
2023
Q4 | $5.64M | Buy |
9,674
+577
| +6% | +$337K | 0.24% | 62 |
|
|
2023
Q3 | $4.89M | Buy |
9,097
+576
| +7% | +$297K | 0.25% | 62 |
|
|
2023
Q2 | $4M | Sell |
8,521
-55
| -0.6% | -$23.1K | 0.2% | 70 |
|
|
2023
Q1 | $2.95M | Buy |
8,576
+2,330
| +37% | +$786K | 0.17% | 78 |
|
|
2022
Q4 | $2.29M | Sell |
6,246
-186
| -3% | -$65.9K | 0.14% | 91 |
|
|
2022
Q3 | $2.08M | Buy |
6,432
+100
| +2% | +$31.7K | 0.12% | 95 |
|
|
2022
Q2 | $2.05M | Buy |
6,332
+63
| +1% | +$18.9K | 0.12% | 98 |
|
|
2022
Q1 | $1.79M | Buy |
6,269
+89
| +1% | +$22.9K | 0.08% | 115 |
|
|
2021
Q4 | $1.71M | Buy |
6,180
+176
| +3% | +$44.6K | 0.08% | 116 |
|
|
2021
Q3 | $1.39M | Buy |
6,004
+312
| +5% | +$77K | 0.07% | 126 |
|
|
2021
Q2 | $1.31M | Sell |
5,692
-498
| -8% | -$100K | 0.07% | 125 |
|
|
2021
Q1 | $1.16M | Buy |
6,190
+227
| +4% | +$44.4K | 0.07% | 132 |
|
|
2020
Q4 | $1.01M | Buy |
5,963
+303
| +5% | +$45.2K | 0.06% | 131 |
|
|
2020
Q3 | $838K | Buy |
5,660
+19
| +0.3% | +$2.94K | 0.06% | 133 |
|
|
2020
Q2 | $926K | Sell |
5,641
-21
| -0.4% | -$3.22K | 0.08% | 112 |
|
|
2020
Q1 | $785K | Sell |
5,662
-1,300
| -19% | -$179K | 0.08% | 115 |
|
|
2019
Q4 | $915K | Buy |
6,962
+116
| +2% | +$13.4K | 0.1% | 124 |
|
|
2019
Q3 | $766K | Buy |
6,846
+202
| +3% | +$22.5K | 0.09% | 122 |
|
|
2019
Q2 | $736K | Sell |
6,644
-29
| -0.4% | -$3.42K | 0.09% | 125 |
|
|
2019
Q1 | $866K | Buy |
6,673
+1,343
| +25% | +$163K | 0.1% | 114 |
|
|
2018
Q4 | $617K | Buy |
5,330
+139
| +3% | +$15.5K | 0.09% | 118 |
|
|
2018
Q3 | $557K | Sell |
5,191
-20
| -0.4% | -$2K | 0.07% | 146 |
|
|
2018
Q2 | $445K | Sell |
5,211
-990
| -16% | -$81.3K | 0.06% | 184 |
|
|
2018
Q1 | $480K | Sell |
6,201
-1,021
| -14% | -$82.2K | 0.07% | 160 |
|
|
2017
Q4 | $610K | Buy |
7,222
+122
| +2% | +$10.4K | 0.07% | 133 |
|
|
2017
Q3 | $607K | Sell |
7,100
-528
| -7% | -$43.3K | 0.08% | 131 |
|
|
2017
Q2 | $628K | Sell |
7,628
-610
| -7% | -$49.8K | 0.09% | 118 |
|
|
2017
Q1 | $693K | Buy |
+8,238
| New | +$660K | 0.17% | 47 |
|
|
2016
Q4 | – | Sell |
-8,303
| Closed | -$666K | – | 161 |
|
|
2016
Q3 | $666K | Buy |
8,303
+76
| +0.9% | +$6.08K | 0.11% | 101 |
|
|
2016
Q2 | $648K | Buy |
8,227
+852
| +12% | +$64.1K | 0.11% | 99 |
|
|
2016
Q1 | $531K | Buy |
7,375
+1,282
| +21% | +$97K | 0.1% | 106 |
|
|
2015
Q4 | $513K | Buy |
6,093
+107
| +2% | +$8.88K | 0.1% | 105 |
|
|
2015
Q3 | $501K | Buy |
5,986
+2,528
| +73% | +$213K | 0.11% | 101 |
|
|
2015
Q2 | $289K | Sell |
3,458
-933
| -21% | -$71.1K | 0.07% | 141 |
|
|
2015
Q1 | $319K | Sell |
4,391
-699
| -14% | -$49.8K | 0.07% | 134 |
|
|
2014
Q4 | $351K | Sell |
5,090
-247
| -5% | -$16.7K | 0.08% | 132 |
|
|
2014
Q3 | $346K | Buy |
5,337
+380
| +8% | +$24.1K | 0.08% | 134 |
|
|
2014
Q2 | $308K | Sell |
4,957
-178
| -3% | -$10.6K | 0.07% | 134 |
|
|
2014
Q1 | $302K | Buy |
5,135
+180
| +4% | +$10K | 0.07% | 132 |
|
|
2013
Q4 | $253K | Sell |
4,955
-1,627
| -25% | -$81.5K | 0.06% | 154 |
|
|
2013
Q3 | $331K | Buy |
+6,582
| New | +$345K | 0.09% | 103 |
|
Other funds holding LLY
VCM
VPM
Brighton Jones LLC's LLY Position: Q1 2026 in Review
Brighton Jones LLC opened a new position in Eli Lilly (LLY) in Q1 2026: 15,617 shares worth $14.4M. The stake represents 0.32% of the portfolio and ranks #44 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in LLY as recently as Q3 2025.
Brighton Jones LLC first reported a position in LLY in Q3 2013 and has held it in 49 quarters since. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Brighton Jones LLC held 15,617 shares of Eli Lilly worth $14.4M as of Q1 2026.
- Eli Lilly was a new Brighton Jones LLC position in Q1 2026.
- Eli Lilly made up 0.32% of Brighton Jones LLC's portfolio in Q1 2026, its #44 holding.
- Brighton Jones LLC first reported a position in Eli Lilly in Q3 2013 and has held it in 49 quarters since.
- 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.